Literature DB >> 11438550

Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis.

N Masuyama1, K Oishi, Y Mori, T Ueno, Y Takahama, Y Gotoh.   

Abstract

Akt is a common mediator of cell survival in a variety of circumstances. Although some candidate Akt targets have been described, the function of Akt is not fully understood, particularly because of the cell type- and context-dependent apoptosis regulation. In this study, we demonstrate that one of the mechanisms by which Akt antagonizes apoptosis involves the inhibition of Nur77, a transcription factor implicated in T-cell receptor-mediated apoptosis. It has been suggested that Akt phosphorylates Nur77 directly, but whether Akt suppresses biological functions of Nur77 remains unknown. We found that Akt inhibited the DNA binding activity of Nur77 and stimulated its association with 14-3-3 in a phosphorylation site-dependent manner. Moreover, we found that expression of Akt suppressed Nur77-induced apoptosis in fibroblasts and activation-induced cell death of T-cell hybridomas. The inhibition of Nur77 by Akt suggests a mechanism that explains how T-cell receptor activation can promote survival in some instances even when Nur77 is induced. Collectively, these results may suggest that Akt is a negative regulator of Nur77 in T-cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438550     DOI: 10.1074/jbc.M105431200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor.

Authors:  Arvind Rajpal; Yuri A Cho; Biana Yelent; Petra H Koza-Taylor; Dongling Li; Elaine Chen; Michael Whang; Chulho Kang; Thomas G Turi; Astar Winoto
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

Review 2.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.

Authors:  Alastair Aitken
Journal:  Plant Mol Biol       Date:  2002-12       Impact factor: 4.076

3.  Disrupting the intermolecular self-association of Itk enhances T cell signaling.

Authors:  Lie Min; Wenfang Wu; Raji E Joseph; D Bruce Fulton; Leslie Berg; Amy H Andreotti
Journal:  J Immunol       Date:  2010-03-17       Impact factor: 5.422

4.  Fas apoptosis inhibitory molecule regulates T cell receptor-mediated apoptosis of thymocytes by modulating Akt activation and Nur77 expression.

Authors:  Jianxin Huo; Shengli Xu; Kong-Peng Lam
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

Review 5.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation.

Authors:  Daniel Lévesque; Claude Rouillard
Journal:  Trends Neurosci       Date:  2006-11-28       Impact factor: 13.837

Review 6.  The role of NR4A transcription factors in memory formation.

Authors:  Josh D Hawk; Ted Abel
Journal:  Brain Res Bull       Date:  2011-02-18       Impact factor: 4.077

7.  Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis.

Authors:  Takashi Sekiya; Ikkou Kashiwagi; Rei Yoshida; Tomohiro Fukaya; Rimpei Morita; Akihiro Kimura; Hiroshi Ichinose; Daniel Metzger; Pierre Chambon; Akihiko Yoshimura
Journal:  Nat Immunol       Date:  2013-01-20       Impact factor: 25.606

8.  ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation.

Authors:  Shuji Wakatsuki; Fuminori Saitoh; Toshiyuki Araki
Journal:  Nat Cell Biol       Date:  2011-11-06       Impact factor: 28.824

9.  Cell-specific phosphorylation of Zfhep transcription factor.

Authors:  Mary E Costantino; Randi P Stearman; Gregory E Smith; Douglas S Darling
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

10.  JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins.

Authors:  Fuminori Tsuruta; Jun Sunayama; Yasunori Mori; Seisuke Hattori; Shigeomi Shimizu; Yoshihide Tsujimoto; Katsuji Yoshioka; Norihisa Masuyama; Yukiko Gotoh
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.